TG Therapeutics, Inc.【TGTX】 業績推移・財務諸表

(単位:千ドル) 3Q11 1Q12 3Q12 1Q13 2Q13 3Q13 1Q14 2Q14 3Q14 1Q15 2Q15 3Q15 4Q15 1Q16 2Q16 3Q16 4Q16 1Q17 2Q17 3Q17 4Q17 1Q18 2Q18 3Q18 4Q18 1Q19 2Q19 3Q19 4Q19 1Q20 2Q20 3Q20 1Q21 2Q21 3Q21 1Q22 2Q22 3Q22 1Q23 2Q23 3Q23 1Q24 2Q24 3Q24 1Q25 2Q25
売上高 - - - - - - - - - - - - - - - - - - - - - - 38 38 - 38 38 38 - 38 38 38 793 1,545 2,030 2,016 594 94 7,803 16,074 165,815 63,474 73,466 83,879 120,856 141,148
売上成長率(%) - - - - - - - - - - - - - - - - - - - - - - - - - - -
売上原価 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 139 - - - - - - - 3,509 5,441 8,304 9,341 15,541 18,938
研究開発費 95 16,741 1,560 1,569 5,027 3,309 4,409 6,848 13,691 9,617 11,261 11,574 - 11,617 13,533 21,797 - 22,681 26,705 27,149 - 35,018 38,700 33,398 - 32,385 32,866 57,985 - 36,022 36,449 50,464 63,094 44,871 51,967 48,042 26,874 20,801 15,870 28,122 14,753 32,722 17,556 20,138 46,362 31,782
販売管理費 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 26,762 34,017 34,899 20,609 12,638 14,254 28,068 30,715 32,769 34,581 38,790 41,966 50,331 55,585
営業費用 - 17,385 2,714 3,752 6,666 4,685 7,643 11,993 17,477 14,640 17,149 13,863 17,678 14,030 16,061 24,963 24,066 27,704 28,463 31,623 31,072 40,615 44,383 34,366 54,188 34,727 35,582 60,899 37,998 50,283 50,883 85,760 89,995 79,036 87,158 68,888 39,535 35,057 44,795 60,748 51,031 72,744 64,650 71,445 112,234 106,305
営業利益 -262 -17,386 -2,715 -3,715 -6,629 -4,648 -7,606 -11,956 -17,440 -14,603 -17,112 -13,826 - -13,993 -16,024 -24,926 - -27,667 -28,426 -31,586 - -41,577 -44,345 -34,328 - -34,689 35,544 -60,861 - -50,245 -50,845 -85,722 -89,202 -77,492 -85,128 -66,872 -38,941 -34,963 -36,992 -44,674 114,784 -9,270 8,816 12,434 8,622 34,843
営業利益率 (%) - - - - - - - - - - - - - - - - - - - - - - - -
経常(税引前)利益 - - - -3,674 -6,585 -4,557 -7,548 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -10,678 6,551 4,268 5,468 30,920
経常(税引前)利益率(%) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -16.82 8.92 5.09 4.52 21.91
法人税等合計 - - - 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 29 -328 388 408 2,700
実効税率(%) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
純利益 -552 -10,257 -2,463 -3,674 -6,585 -4,557 -7,548 -11,987 -17,452 -14,578 -17,104 -13,656 - -13,849 -15,900 -24,832 - -27,728 -28,354 -31,536 - -41,529 -44,142 -33,951 - -35,156 36,213 -61,930 - -51,116 -52,884 -87,163 -90,628 -78,497 -85,637 -69,013 -40,510 -35,818 -39,232 -47,610 113,930 -10,707 6,879 3,880 5,060 28,187
純利益率(%) - - - - - - - - - - - - - - - - - - - - - - - -
一株あたり利益 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -0.51 -0.3 -0.26 -0.28 -0.34 0.8 -0.07 0.05 0.03 0.03 0.19
希薄化後一株あたり利益 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -0.51 -0.3 -0.26 -0.28 -0.34 0.73 -0.07 0.04 0.02 0.03 0.17
EBITDA - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
EBITDAマージン(%) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -